Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly

NCT00968890 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Pandemrix (Influenza vaccine GSK2340272A)
BIOLOGICAL: Fluarix™
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline